<DOC>
	<DOCNO>NCT01536626</DOCNO>
	<brief_summary>This study conduct Europe . The aim observational study observe investigate process switch premixed human insulin 30/70 ( BHI 30 ) biphasic insulin aspart 30/70 ( BIAsp 30 ) outpatient setting .</brief_summary>
	<brief_title>Switch From Premixed Human Insulin Biphasic Insulin Aspart Netherlands</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetic subject treat BHI 30</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>